Latest filing published 06 Mar 2014 for Insys Therapeutics, Inc., €149k.
No signal scores available.
Filings by Larry Dillaha span 2 companies, the busiest being Insys Therapeutics, Inc. and First Horizon Pharmaceutical Corp. We count 25 filings; the first trade dates from 9 August 2006 and the latest from 5 March 2014.
Every open-market trade on record is a sale: 17 sales worth €8.3M. Besides market trades, the filings include 5 share grants and 3 option exercises. In 2014 alone, the filings show no purchases and 10 sales.
The latest filing, published on 6 March 2014, reports an open-market sale of €279k in Insys Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations